Morgan Stanley
MRNA icon

Morgan Stanley’s Moderna MRNA Stock Holding History

Quarter Market Value Status Shares Shares
Change %
Trade Value Portfolio Weight Portfolio Position
2025
Q2
$224M Buy
8,103,538
+665,133
+9% +$18.4M 0.01% 823
2025
Q1
$211M Buy
7,438,405
+3,190,707
+75% +$90.5M 0.02% 812
2024
Q4
$177M Buy
4,247,698
+738,609
+21% +$30.7M 0.01% 902
2024
Q3
$235M Sell
3,509,089
-1,497,431
-30% -$100M 0.02% 744
2024
Q2
$595M Sell
5,006,520
-487,445
-9% -$57.9M 0.05% 378
2024
Q1
$585M Sell
5,493,965
-3,284,251
-37% -$350M 0.05% 383
2023
Q4
$873M Buy
8,778,216
+3,466,202
+65% +$345M 0.04% 451
2023
Q3
$549M Sell
5,312,014
-505,071
-9% -$52.2M 0.06% 328
2023
Q2
$707M Buy
5,817,085
+866,512
+18% +$105M 0.07% 265
2023
Q1
$760M Buy
4,950,573
+763,220
+18% +$117M 0.08% 238
2022
Q4
$752M Buy
4,187,353
+670,284
+19% +$120M 0.09% 231
2022
Q3
$416M Buy
3,517,069
+35,547
+1% +$4.2M 0.06% 330
2022
Q2
$497M Buy
3,481,522
+570,718
+20% +$81.5M 0.06% 295
2022
Q1
$501M Sell
2,910,804
-1,930,052
-40% -$332M 0.07% 266
2021
Q4
$1.23B Sell
4,840,856
-820,531
-14% -$208M 0.15% 146
2021
Q3
$2.18B Sell
5,661,387
-1,760,110
-24% -$677M 0.29% 72
2021
Q2
$1.74B Sell
7,421,497
-801,291
-10% -$188M 0.23% 101
2021
Q1
$1.08B Buy
8,222,788
+2,427,704
+42% +$318M 0.16% 143
2020
Q4
$605M Buy
5,795,084
+761,697
+15% +$79.6M 0.09% 199
2020
Q3
$356M Sell
5,033,387
-1,350,738
-21% -$95.6M 0.07% 252
2020
Q2
$410M Buy
6,384,125
+899,098
+16% +$57.7M 0.09% 202
2020
Q1
$164M Buy
5,485,027
+675,919
+14% +$20.2M 0.04% 356
2019
Q4
$94.1M Buy
4,809,108
+303,041
+7% +$5.93M 0.02% 637
2019
Q3
$71.7M Sell
4,506,067
-228,975
-5% -$3.65M 0.02% 684
2019
Q2
$69.3M Buy
4,735,042
+1,321,777
+39% +$19.4M 0.02% 696
2019
Q1
$69.5M Buy
3,413,265
+1,260,145
+59% +$25.6M 0.02% 675
2018
Q4
$32.9M Buy
+2,153,120
New +$32.9M 0.01% 1060